INM — InMed Pharmaceuticals Inc.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1728328 · British Columbia, Canada
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
2026-11-03

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 0 — -2,010,808 -2,330,778 1,305,862 1,094,488 2,505,258
Jun 2026 0 — -3,211,149 -5,839,392 3,030,067 2,194,413 1,955,060
Mar 2026 0 — -2,816,353 -2,966,336 9,133,806 5,158,932 2,242,032
Dec 2025 820,188 184,194 -2,120,738 -2,028,223 11,191,484 6,954,834 1,603,820

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-9,459,785
Investing CF
$2,417
Financing CF
$271,674
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-21.00
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-132,561,184
Inventory
$947,898
Receivables
$182,967
ST Investments
—
EBIT TTM
$-11,663,144
Pretax Income TTM
$-11,658,048
Interest Exp TTM
$30,700
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$4,942,633
EBITDA
$-9,886,568
Free Cash Flow
$-2,728,912
Enterprise Value
$84,347,696
Total Cash
$1,134,819
Total Debt
$0
Shares Out
549,374
Trailing EPS
$-27.60
Book Value
$-0.22
ROE
-222.1%
ROA
-85.6%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Jun 2026 0 -9,895,116 -12,560,850 3,030,067 1,955,060 1,075,007 -8,643,513
Jun 2025 0 -8,446,170 -8,162,133 15,580,040 2,145,545 13,434,495 -8,099,392
Jun 2024 4,597,730 -8,134,430 -7,675,550 11,822,782 2,616,673 9,206,109 -6,985,832
Jun 2023 4,135,561 -8,378,787 -7,947,622 14,106,340 2,016,613 12,089,727 -7,283,199
Jun 2022 — — — — — — —

TTM Snapshot

Revenues TTM
$244,971
NetIncome TTM
$-12,560,850
OpCashFlow TTM
—
Assets (Latest)
$9,133,806
Forward EPS
$-6.25

Peers — same industry

TickerNameMarket CapLastDaily %
LLY ELI LILLY & Co $1.26T $1415.55 —
JNJ JOHNSON & JOHNSON $670.92B $278.70 —
ABBV AbbVie Inc. $517.59B $292.82 —
MRK Merck & Co., Inc. $353.44B $143.37 —
NVS NOVARTIS AG $302.46B $159.13 —

News headlines (Yahoo Finance, 1h cache)

Mentari Therapeutics Announces Closing of Merger with InMed Pharmaceuticals and Previously Announced $490 Million Financing
2026-11-09 12:00 · Yahoo
Fox-Roku’s $22B Deal, A New Nasdaq Biotech And A $25B Chemicals Tie-Up: Deals Investors Are Watching
2026-11-09 06:16 · Yahoo
InMed Pharmaceuticals Completes Closing of Merger with Mentari Therapeutics
2026-11-06 21:05 · Yahoo
InMed Announces Expected Closing of Merger and Commencement of Trading on Nasdaq Under the Name "Mentari Therapeutics, Inc." and Ticker Symbol "MTRI"
2026-11-05 21:01 · Yahoo
InMed Announces Results of 2026 Annual General and Special Meeting, Approval of Corporate Name Change and Completion of Share Consolidation
2026-11-04 21:51 · Yahoo
InMed Reports First Quarter Fiscal 2027 Financial Results and Provides Corporate Update
2026-11-03 12:30 · Yahoo
InMed Announces Share Consolidation in Connection with Proposed Merger
2026-11-02 21:15 · Yahoo
InMed-Mentari Migraine Merger Backed by $290 Million Financing Reshapes Company Strategy (INM)
2026-05-19 14:37 · Yahoo
/C O R R E C T I O N -- InMed Pharmaceuticals/
2026-05-19 18:21 · Yahoo
InMed Pharmaceuticals Regains Compliance with Nasdaq Continued Listing Requirements
2026-06-04 21:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.